Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Dong-A ST Co., Ltd.
  6. Summary
    A170900   KR7170900005

DONG-A ST CO., LTD.

(A170900)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
86400 83900 83200 82300 82500 Last
651285 240658 143909 106865 58474 Volume
-12.90% -2.89% -0.83% -1.08% +0.24% Change
Estimated financial data (e)
Sales 2021 624 B 0,54 B 0,54 B
Net income 2021 27,2 B 0,02 B 0,02 B
Net cash position 2021 69,0 B 0,06 B 0,06 B
P/E ratio 2021 25,5x
Yield 2021 1,21%
Sales 2022 650 B 0,56 B 0,56 B
Net income 2022 42,1 B 0,04 B 0,04 B
Net cash position 2022 134 B 0,12 B 0,12 B
P/E ratio 2022 16,5x
Yield 2022 1,21%
Capitalization 696 B 604 M 603 M
EV / Sales 2021 1,01x
EV / Sales 2022 0,87x
Nbr of Employees -
Free-Float 56,2%
More Financials
Company
Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
More about the company
Ratings of Dong-A ST Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about DONG-A ST CO., LTD.
07/22Intas Pharmaceuticals Limited Enters into an Exclusive License Agreement with..
CI
02/08Dong-A ST Co., Ltd. Completes the Proof-Of-Concept Study for ĹDA-1241,’ an In..
CI
2020DONG-A ST CO., LTD.(KOSE : A170900) dropped from KOSPI 200 Index
CI
2019Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaborat..
CI
2018Neurobo Pharma Enters into Licensing Agreement with Dong-A ST
CI
2017Dong-A and Pharmasyntez Consider Joint Venture for Russian Drug Manufacture
CI
2017Dong-A ST Co., Ltd. Enters into License Agreement with AbbVie, Inc
CI
2016ST Pharm Co.,Ltd. cancelled the acquisition of Banwol Factory from Dong-A ST ..
CI
More news
News in other languages on DONG-A ST CO., LTD.

- No features available -

More news
Chart DONG-A ST CO., LTD.
Duration : Period :
Dong-A ST Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DONG-A ST CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Last Close Price 82 500,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Dae-Sik Eom Chief Executive Officer & Director
Hyeong-Heon Kim Head-Compliance Support
Geun-Soo Kim Independent Director
Jae-Sang Ryu Independent Director
Hui-Joo Choi Independent Director
Sector and Competitors